申请人:Catalyst Biosciences, Inc.
公开号:US10258582B2
公开(公告)日:2019-04-16
The present invention relates to compounds that modulate nicotinic receptors as non-competitive antagonists, methods for their synthesis, methods for use, and their pharmaceutical compositions.
本发明涉及作为非竞争性拮抗剂调节烟碱受体的化合物、其合成方法、使用方法及其药物组合物。